Cargando…

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study

BACKGROUND: Treatment-resistant schizophrenia is a major disabling illness which often proves challenging to manage in a secondary care setting. The National Psychosis Unit (NPU) is a specialised tertiary in-patient facility that provides evidence-based, personalised, multidisciplinary interventions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casetta, Cecilia, Gaughran, Fiona, Oloyede, Ebenezer, Onwumere, Juliana, Pritchard, Megan, Shergill, Sukhi S., Whiskey, Eromona, MacCabe, James Hunter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453801/ https://www.ncbi.nlm.nih.gov/pubmed/32744200 http://dx.doi.org/10.1192/bjo.2020.51

Ejemplares similares

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
por: Green, Alastair, et al.
Publicado: (2019)

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
por: Livermore, Cecilia, et al.
Publicado: (2022)

Physical Health Problems in Psychosis: Is It Time to Consider the Views of Family Carers?
por: Onwumere, Juliana, et al.
Publicado: (2018)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Unheard voices: outcomes of tertiary care for treatment-refractory psychosis
por: Sarkar, S. Neil, et al.
Publicado: (2014)

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
por: Rodriguez, Victoria, et al.
Publicado: (2020)

Prevalence of serum N-methyl-d-aspartate receptor autoantibodies in refractory psychosis
por: Beck, Katherine, et al.
Publicado: (2015)

Unheard voices: outcomes of tertiary care for treatment-refractory psychosis — ADDENDUM
por: Sarkar, S. Neil, et al.
Publicado: (2019)

Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy – ERRATUM
por: Segev, Aviv, et al.
Publicado: (2021)

Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracy
por: Segev, Aviv, et al.
Publicado: (2021)

Rehabilitation or Stagnation? a Six Month Mirror-Image Study Reviewing the Effectiveness of an Inpatient Rehabilitation Unit
por: Kapila, Adisha, et al.
Publicado: (2022)

What are the barriers and facilitators of clozapine use in early psychosis? A survey of UK early intervention clinicians
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical Trial
por: Gaughran, Fiona, et al.
Publicado: (2021)

Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitals
por: Oloyede, Ebenezer, et al.
Publicado: (2021)

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
por: Lowe, Penelope, et al.
Publicado: (2017)

Clozapine for treatment resistance in early psychosis: a survey of UK clinicians’ training, knowledge and confidence
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
por: Egerton, Alice, et al.
Publicado: (2022)

The relationship between nicotine and psychosis
por: Quigley, Harriet, et al.
Publicado: (2019)

M189. A PILOT RANDOMISED CONTROLLED TRIAL TO ASSESS THE FEASIBILITY AND ACCEPTABILITY OF HIGH INTENSITY INTERVAL TRAINING (HIIT) AMONG INPATIENTS WITH SEVERE MENTAL ILLNESS (SMI)
por: Martland, Rebecca, et al.
Publicado: (2020)

Study protocol for a pilot high-intensity interval training intervention in inpatient mental health settings: a two-part study using a randomised controlled trial and naturalistic study design
por: Martland, Rebecca, et al.
Publicado: (2021)

Perspectives on implementing HIIT interventions for service users in inpatient mental health settings: a qualitative study investigating patient, carer and staff attitudes
por: Martland, Rebecca, et al.
Publicado: (2021)

A symptom-based approach to treatment of psychosis in autism spectrum disorder
por: Bell, Victoria, et al.
Publicado: (2018)

Lifestyle Interventions in Preventing Excess Weight Gain in First Episode of Psychosis (FEP): A Systematic Review
por: Adeoye, Margret, et al.
Publicado: (2023)

A symptom-based approach to treatment of psychosis in autism spectrum disorder in October 2017–ERRATUM
por: Bell, Victoria, et al.
Publicado: (2018)

Social isolation and psychosis: an investigation of social interactions and paranoia in daily life
por: Fett, Anne-Kathrin J., et al.
Publicado: (2021)

Reducing the Risk of Withdrawal Symptoms and Relapse Following Clozapine Discontinuation—Is It Feasible to Develop Evidence-Based Guidelines?
por: Blackman, Graham, et al.
Publicado: (2021)

The neural mechanisms of social reward in early psychosis
por: Fett, Anne-Kathrin J, et al.
Publicado: (2019)

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020)

It is time to start taking tobacco seriously as a risk factor for psychosis: self‐medication cannot explain the association
por: MacCabe, J. H.
Publicado: (2018)

COVID-related hospitalization, intensive care treatment, and all-cause mortality in patients with psychosis and treated with clozapine
por: Govind, Risha, et al.
Publicado: (2022)

Digital Technology for Caregivers of People With Psychosis: Systematic Review
por: Onwumere, Juliana, et al.
Publicado: (2018)

Informal Caregiving Relationships in Psychosis: Reviewing the Impact of Patient Violence on Caregivers
por: Onwumere, Juliana, et al.
Publicado: (2018)

TMS-EEG in the Investigation of Excitation-Inhibition Imbalance in Psychosis and Cognition
por: Michalopoulou, Panayiota G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vjc2seq00m4li4vs6dc4eb47fe